RxDoctor Payments Data

Stephen Rosenberg

Radiation Oncology · Madison, WINPI 1932441656

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $11,690 of the $17,936 with a category attached, or 65.2%. 6 manufacturers reported payments, led by Novocure Inc. at 53.6% of the total. Reporting peaked in 2022 at $9,686 and has fallen 99.9% since, to $14 in 2025. Among radiation oncology clinicians in WI with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$17,936in general payments, 2019–2025

Across 34 payments — averaging $527.52 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novocure Inc.$10K
  • Viewray Technologies Inc$4K
  • Novocure GmbH$2K
  • Elekta, Inc.$1K
  • GE HealthCare$249
  • LEO Pharma Inc.$14
$84,039in research payments, 2019–2025

Across 3 payments — averaging $28,013 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Novocure Inc.$76K
  • Viewray Technologies Inc$8K

What the payments were for

  • Consulting fees$11,69065%
  • Speaking & faculty fees$3,25018%
  • Travel & lodging$8615%
  • Food & beverage$2,13512%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$17,936 in reported general payments places this provider in the 95th percentile of 131 radiation oncology providers in Wisconsin.

See all radiation oncology providers in Wisconsin

Medicare billing

Part B allowed, 2024
$179,262
Medicare patients
330
Services billed
1,990

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Betamethasone Valerate17$373
Sucralfate15$154
Pantoprazole Sodium15$111
Methylprednisolone13$89

Paid to pharmacies, not to this prescriber.

Other radiation oncology in Madison

See the full list for Wisconsin

Where these figures come from

Is this you, or does something look wrong? →